Adjuvant chemotherapy for invasive bladder cancer (individual patient data)

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 4, 2006, Pages

  Vale, Claire L ^a  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85126510572     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006018     Document Type: Review

References (25)

1. Bono AV, Benvenuti C, Gibba A, Guazzeri S, Cosciani-Cunico S, Anselmo G, Martini E, Parma G, Ferrari P, Viggiano G. Adjuvant chemotherapy in locally advanced bladder cancer. Final analysis of a controlled multicentre study. Acta Urol Ital 1997;11(1):5-8.
2. Freiha F, Reese J, Torti F.M. A Randomised Trial of Radical Cystectomy versus Radical Cystectomy plus Cisplatin, Vinblastine and Methotrexate Chemotherapy for Muscle Invasive Bladder Cancer. Journal of Urology 1996;155:495-500 4495-500.
3. Otto T, et al. University of Essen RCT of adjuvant chemotherapy in bladder cancer. Unpublished 2001.
4. Skinner DG, Daniels JR, Russel CA, Lieskovsky G, Boyd SD, Krailo M, Groshen S. Adjuvant chemotherapy following cystectomy benefits patients with deeply invasive bladder cancer. Seminars in Urology 1990;8(4):279-284.
5. Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossman M, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R. Adjuvant polychemotherapy of non-organ confined bladder cancer after radical cystectomy revisited: long term results of a controlled prospective study and further clinical experience. Journal of Urology 1995;153:47-52.
6. Studer UE, Bacchi M, Biedermann C, Jaeger P, Kraft R, Mazzucchelli L, Markwalder R, Senn E, Sonntag RW. Adjuvant Cisplatin Chemotherapy following cystectomy for bladder cancer: Results of a prospective randomised trial. Journal of Urology 1994;152:81-84.
7. Allen TD. Phase III Randomized Evaluation of Postoperative Chemotherapy with CACP for Invasive Nonmetastatic Transitional Cell Carcinoma of the Bladder (NCI-D78-044-145). Unpublished.
8. Einstein AB, Shipley W, Coombs J, Cummings KB, Soloway MS, Hawkins I, for the National Bladder Cancer Cooperative Group. Cisplatin as adjunctive treatment for invasive bladder carcinoma: Tolerance and toxicities. Urology 1984;23(4 (suppl)):110-117.
9. Omura G. Phase III Adjuvant Chemotherapy with CTX/ADR/CACP for Resected Transitional Cell Bladder Carcinoma (SEG-78BL339). Unpublished.
10. Richards B, Bastable JRG, Freedman L, Glashan RW, Harris G, Newling DWW, Robinson MRG, Smith PH. chemotherapy with doxorubicin, and 5-florouracil in T3, NX, MO bladder cancer treated with radiotherapy. British Journal of Urology 1983;55:386-391.
11. Shearer RJ, Chilvers CED, Bloom HJG, Bliss JM, Horwich A, Babiker A. Chemotherapy in T3 Carcinoma of the Bladder A prospective trial: preliminary report. British Journal of Urology 1988;62:558-564.
12. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 2003;361:1927-1934.
13. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. British Medical Journal 1994;309:1286-1291.
14. Green SJ, Fleming TR, Emerson S. Effects of overviews of early stopping rules for clinical trials. Statistics in Medicine 1987;6:361-367.
15. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327:557-560.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. Journal of the American Statistical Association 1958;53:457-481.
17. Parkin DM, Pisani P, Ferlay J. Global Cancer Statistics. CA: a Cancer Journal for Clinicians 1999;49:33-64.
18. Parmar, Mahesh K. B, Machin, David. Survival analysis: a practical approach. John Wiley & Sons Ltd, 1995.
19. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815-34.
20. Parmar Mahesh K. B, Burdett Sarah. Neoadjuvant and adjuvant chemotherapy. In: Hall RR editor(s). Clinical management of bladder cancer. 1. London: Arnold, 1999:249-263.
21. Stewart LA, Clarke MJ, on behalf of the Cochrane Working Party Group on Meta-analysis using Individual Patient Data. Practical methodology of meta-analyses (overviews) using updated individual patient data. Statistics in Medicine 1995;14:2057-2079.
22. Sylvester R, Sternberg C. The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why. Annals of Oncology 2000;11:851-856.
23. Tierney JF, Stewart LA. Investigating patient exclusion bias in meta-analysis. International Journal of Epidemiology 2005;34:79-87.
24. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: An overview of the randomized trials. Progress in Cardiovascular Disease 1985;27:335-371.
25. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant Chemotherapy in Invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Patient Data. European Urology 2005;In press.